Sigyn Therapeutics, Inc. (SIGY) Form 10-K Annual Reports
Sigyn Therapeutics, Inc. (SIGY) is a publicly traded company on the OTC, categorized under SIC 3841 (Surgical & Medical Instruments & Apparatus). Access real-time SEC filings, 10-K annual reports, 10-Q quarterlies, 8-K current reports, PCAOB auditor history, and executive compensation disclosures.
Ticker: SIGY
CIK: 1642159
Exchange: OTC
SIC 3841: Surgical & Medical Instruments & Apparatus
Fiscal Year End: 12/31
State: DE
Independent PCAOB Auditor
Explore PCAOB Audit Intelligence →
Audit Firm
Kreit & Chiu CPA LLP
Auditor SinceSince 12/31/2022 12:00:00 AM
Lead Engagement PartnerJohn Delarosa
Audit LocationLos Angeles, California, United States
Latest SEC EDGAR Filings
Showing 10-K, 10-Q, 8-K, Form 4, and other SEC submissions| Form | Filing Date | Reporting Period | Description | Accession Number | Actions |
|---|---|---|---|---|---|
| 15-12G | 2026-07-16 | — | 15-12G | 0001493152-26-033421 | View SEC Doc Filr Page |
| NT 10-K | 2026-03-31 | 2025-12-31 | NT 10-K | 0001493152-26-014344 | View SEC Doc Filr Page |
| 8-K | 2026-02-20 | 2026-02-20 | 8-K | 0001493152-26-007574 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2026-01-14 | — | SCHEDULE 13G/A Filing | 0001213900-26-004186 | View SEC Doc Filr Page |
| 10-Q | 2025-11-14 | 2025-09-30 | 10-Q | 0001493152-25-023387 | View SEC Doc Filr Page |
| 10-Q | 2025-09-05 | 2025-06-30 | 10-Q | 0001641172-25-026704 | View SEC Doc Filr Page |
| 8-K | 2025-08-15 | 2025-08-14 | 8-K | 0001641172-25-024303 | View SEC Doc Filr Page |
| NT 10-Q | 2025-08-15 | 2025-06-30 | NT 10-Q | 0001641172-25-024221 | View SEC Doc Filr Page |
| 10-Q | 2025-05-20 | 2025-03-31 | 10-Q | 0001641172-25-011815 | View SEC Doc Filr Page |
| NT 10-Q | 2025-05-15 | 2025-03-31 | NT 10-Q | 0001641172-25-010720 | View SEC Doc Filr Page |
| 10-K | 2025-04-15 | 2024-12-31 | 10-K Filing | 0001641172-25-004740 | View SEC Doc Filr Page |
| NT 10-K | 2025-03-31 | 2024-12-31 | NT 10-K Filing | 0001641172-25-001760 | View SEC Doc Filr Page |
| 8-K | 2025-03-07 | 2025-02-26 | 8-K Filing | 0001493152-25-009462 | View SEC Doc Filr Page |
| SCHEDULE 13G/A | 2025-02-14 | — | SCHEDULE 13G/A Filing | 0001213900-25-014469 | View SEC Doc Filr Page |
| 8-K | 2025-01-16 | 2025-01-11 | 8-K Filing | 0001493152-25-002575 | View SEC Doc Filr Page |
| 8-K | 2025-01-06 | 2024-12-30 | 8-K Filing | 0001493152-25-001074 | View SEC Doc Filr Page |
| 10-Q | 2024-11-19 | 2024-09-30 | 10-Q Filing | 0001493152-24-046847 | View SEC Doc Filr Page |
| NT 10-Q | 2024-11-15 | 2024-09-30 | NT 10-Q Filing | 0001493152-24-046127 | View SEC Doc Filr Page |
| 8-K | 2024-10-16 | 2024-10-07 | 8-K Filing | 0001493152-24-041287 | View SEC Doc Filr Page |
| 8-K/A | 2024-10-16 | 2024-10-04 | 8-K/A Filing | 0001493152-24-041285 | View SEC Doc Filr Page |
| 8-K | 2024-10-07 | 2024-10-04 | 8-K Filing | 0001493152-24-039594 | View SEC Doc Filr Page |
| RW | 2024-08-30 | — | RW Filing | 0001493152-24-034654 | View SEC Doc Filr Page |
| 10-Q | 2024-08-19 | 2024-06-30 | 10-Q Filing | 0001493152-24-033048 | View SEC Doc Filr Page |
| NT 10-Q | 2024-08-14 | 2024-06-30 | NT 10-Q Filing | 0001493152-24-032398 | View SEC Doc Filr Page |
| 8-K | 2024-06-06 | 2024-06-06 | 8-K Filing | 0001493152-24-022945 | View SEC Doc Filr Page |